Americans for Ibogaine

What Americans for Ibogaine does

Americans for Ibogaine Inc. (AFI) is a 501(c)(3) public charity founded in June 2025 and governed by Texas law, with its operational base in the United States. The organization is dedicated to advancing public understanding and responsible medical access to ibogaine — a naturally occurring psychoactive compound derived from Tabernanthe iboga — for the treatment of opioid addiction, PTSD, traumatic brain injury, and co-occurring mental health conditions. AFI's core work is advocacy and education rather than treatment delivery or product sales; it does not provide ibogaine therapy, manufacture compounds, or fund clinical trials directly. Its outputs consist of an educational website and research library, a state-by-state legislative tracker, an ambassador program featuring veterans, athletes, and recovery advocates, a partner referral directory of vetted treatment and scholarship organizations (including Athletes for Care, Forward Intent, Heroic Hearts Project, VETS Inc., Mission To Live Foundation, and the Casey Skudin 343 Fund), and a newsletter / social media presence that drives donor engagement.

The organization's strategic focus is on advancing ibogaine through the FDA approval pathway rather than via decriminalization, an explicit Code of Ethics that anchors its credibility with state legislators and academic medical centers. AFI has been closely associated with landmark state legislative outcomes, including Texas SB 2308 ($50M in June 2025, with announced intent to reach $100M total), Kentucky SB 77 ($21M/year through 2028, veto overridden April 2026), Arizona HB 2871 ($5M), Mississippi HB 314 ($5M), Oklahoma HB 3834, California AB 1103, and Indiana HB 1001. Its research partners include UTHealth Houston and UTMB Health, which were awarded Texas's $50M clinical trial grant in December 2025. The organization is governed by a Board chaired by former Texas Governor and U.S. Secretary of Energy Rick Perry, with CEO W. Bryan Hubbard (former chairman of Kentucky's Opioid Abatement Advisory Commission), Chief Communications Officer AnneClaire Stapleton (former CNN conflict correspondent), and board members Marcus and Melanie Luttrell.

AFI's business model is exclusively donation-driven. Revenue is generated through tax-deductible contributions from individuals, philanthropists, and foundations, including a recurring "Give Monthly" program; no fee-for-service, product sales, or treatment pricing exists. Marketing is conducted through earned media (75+ features in NYT, WSJ, NPR, Fox News, PBS, Politico, USA Today, Washington Post), high-profile podcast appearances (Joe Rogan Experience twice, Duncan Trussell Family Hour, Aubrey Marcus, Hamilton Morris, Theo Von, Jillian Michaels), a Fox Nation documentary, SXSW panels, owned social channels (LinkedIn, Instagram, Twitter/X, Facebook), and direct legislative engagement across 15+ states.

Name

Americans for Ibogaine

Legal name

Americans for Ibogaine Inc.

Website

https://americansforibogaine.org

Company type

Private

Founded year

2025

Operating status

Operating

Headcount range

1–10 employees

Short description

Americans for Ibogaine is a U.S. 501(c)(3) nonprofit founded in June 2025 that advocates for FDA-approved ibogaine therapy through state legislative action, public education, and a coalition of veterans, first responders, athletes, and researchers serving those with opioid use disorder, PTSD, and traumatic brain injury.

Ownership category

akta.pro rank

Product category

Health Advocacy & Policy Services

NAICS

Educational Support Services (611710), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Educational Services (8200)

akta.pro primary industry

Substance Use Prevention & Recovery Lifestyle Education (Non-clinical) (EDAAAHAL)

akta.pro secondary industry

Regulatory Strategy & IND/NDA/BLA Submissions Support (HLAIALAH)

Keywords

• Ibogaine research advocacy
• Psychedelic therapy policy
• Nonprofit health advocacy
• Veteran mental health
• Substance use disorder

Headquarters

HQ city

Austin

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Marketing or Sales, Operations, Others, Infrastructure

Revenue model

1. Tax-Deductible Donations: Americans for Ibogaine generates revenue primarily through tax-deductible charitable contributions from individuals, philanthropists, and foundations. As a 501(c)(3) nonprofit, donations are the principal funding mechanism supporting education, advocacy, and research support activities. The organization also runs monthly giving programs (Give Monthly). No fee-for-service or product revenue is generated since the organization does not provide treatment or sell products.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels10 records

Core offering

Americans for Ibogaine (AFI) is a 501(c)(3) nonprofit education and advocacy organization that promotes scientific research, reduces stigma, and educates the public to accelerate safe, evidence-based adoption of ibogaine therapy for addiction, trauma, and co-occurring mental health conditions. The organization's primary outputs are an educational awareness platform about ibogaine's science and research, legislative advocacy and coalition-building with state/federal policymakers, and clinical trial advocacy supporting the FDA approval pathway. AFI does not provide treatment, manufacture products, or sell services; its core work centers on advocacy, research support, and public education funded by tax-deductible donations.

Product overview

Americans for Ibogaine (AFI) is a 501(c)(3) nonprofit education and advocacy organization that operates as a platform of interconnected services rather than a single product. The core offerings include an Educational Resources & Awareness Platform providing science-based ibogaine information; Legislative Advocacy & Policy Engagement working with state and federal lawmakers; Research Support & Clinical Trial Advocacy advancing FDA-pathway studies; a Newsletter & Email Communications system for supporters; an Ambassador Program featuring personal recovery stories; Partner Organization Resources & Referrals connecting individuals with treatment providers; and Donation Processing for tax-deductible contributions. The organization does not provide ibogaine treatment, medical advice, or financial assistance for therapy.

Differentiator

Problem solved

Functional benefit

Products and services

• Educational Resources & Awareness Platform Online educational platform hosted at americansforibogaine.org providing science-based information about ibogaine — including how it works, research findings, safety considerations, and FAQs — to advance public understanding of ibogaine for addiction, trauma, and co-occurring mental health conditions. Targets the general public, veterans, first responders, athletes, and policymakers.
• Legislative Advocacy & Policy Engagement Coalition-building and direct advocacy services that work with state and federal legislators to advance responsible, medically-focused ibogaine legislation through the FDA approval pathway. Includes state-by-state legislation tracking (active in 15+ states), research summaries, briefing materials, and policy resources that shape legislation such as Texas SB 2308 ($50M), Arizona HB 2871 ($5M), and Mississippi HB 314 ($5M).

Quantifiable outcome

• Significant reductions in PTSD symptoms, depression, and anxiety that persisted at one-month follow-up (Stanford University Ibogaine Trial, Nature Medicine, 2024)
• +4 more outcomes

Named customers4 records

Segments6 records

Ideal customer profiles6 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Nine partnerships are on record, tiered core and minor.

• UTHealth HoustoncoreStrategic or Co-development Partner · 1 June 2025In December 2025, UTHealth Houston, in collaboration with UTMB Health, was awarded $50 million by the state of Texas to lead ibogaine clinical trials. This represents the primary institutional research partner for AFI's advocacy work, conducting the largest state-funded ibogaine research initiative in U.S. history.
• UTMB Health (University of Texas Medical Branch)coreStrategic or Co-development Partner · 1 June 2025Collaborating with UTHealth Houston to lead FDA-supervised ibogaine clinical trials funded by the state of Texas ($50 million award in December 2025). UTMB Health serves as the clinical research partner conducting the trials.
• Athletes for CarecoreGTM or Marketing PartnerA nonprofit organization serving current and former athletes dealing with TBI, CTE, mental health conditions, and addiction. AFI partners with Athletes for Care to connect athletes with ibogaine treatment resources and to amplify the organization's mission within the athletic community. Featured on AFI's Get Help page as a vetted partner organization.
• The Casey Skudin 343 FundcoreGTM or Marketing PartnerSupporting first responders with access to ibogaine and alternative mental health treatments. AFI partners with The Casey Skudin 343 Fund to serve the first responder community. Featured on AFI's Get Help page and highlighted in joint media appearances (GO Talk Texas with Angela Skudin).
• Forward IntentcoreGTM or Marketing PartnerSupporting over 1,000 veterans since 2017 with access to alternative treatments. Forward Intent is a partner organization that connects veterans with ibogaine and alternative mental health therapies, and is listed on AFI's Get Help page as a vetted partner.
• Heroic Hearts ProjectcoreGTM or Marketing PartnerConnecting military veterans with psychedelic therapy programs for PTSD and TBI. Heroic Hearts Project is a partner organization serving veterans and is listed on AFI's Get Help page as a vetted resource for ibogaine and psychedelic-assisted therapy access.
• Mission To Live FoundationcoreGTM or Marketing PartnerProviding scholarships for veterans and first responders seeking ibogaine and alternative treatments. The Mission To Live Foundation is listed on AFI's Get Help page as a partner providing financial assistance for treatment access.
• VETS, Inc.coreGTM or Marketing PartnerServing over 1,000 veterans of special operations with access to ibogaine and other psychedelic-assisted therapies. Listed on AFI's Get Help page as a vetted partner organization for veteran ibogaine access.
• Inner Vision Ibogaine CoachingminorGTM or Marketing PartnerProviding pre- and post-treatment integration coaching for individuals who have undergone or are considering ibogaine therapy. Listed on AFI's Get Help page as a partner providing integration coaching services.

Scale indicators5 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Usona Institute: Nonprofit sponsoring psilocybin clinical trials for depression and supporting psychedelic research infrastructure. Comparable as a 501(c)(3) funding and advancing psychedelic FDA clinical research.
• Heroic Hearts Project: Veteran-focused nonprofit connecting military veterans with psychedelic therapy programs for PTSD and TBI. AFI lists this organization as a vetted Get Help partner; directly comparable in mission and target population.
• Forward Intent: Nonprofit supporting over 1,000 veterans since 2017 with access to alternative treatments including ibogaine. AFI partner; directly comparable as a veteran-ibogaine access organization.
• MAPS (Multidisciplinary Association for Psychedelic Studies): The leading nonprofit psychedelic research and education organization in the U.S., pursuing FDA approval for MDMA-assisted therapy. Directly comparable as a psychedelic-focused advocacy/research nonprofit operating on a similar FDA-pathway, donation-funded model.
• VETS, Inc. Nonprofit serving special operations veterans with access to ibogaine and psychedelic-assisted therapies. AFI partner; directly comparable in veteran-focused ibogaine access advocacy.
• Athletes for Care: Nonprofit serving current and former athletes with TBI, CTE, mental health, and addiction. AFI partner; comparable in athlete-population advocacy and treatment referral.

Broad incumbents

• Beckley Foundation: UK-based psychedelic research and policy advocacy foundation with a global footprint. Comparable as a psychedelic research-advocacy organization, though international rather than U.S.-focused.
• Compass Pathways: Public biotech developing psilocybin therapy for treatment-resistant depression. Comparable as a psychedelic therapy organization pursuing FDA approval, though operating as a commercial for-profit rather than nonprofit.
• MindMed: Public biotech developing psychedelic-inspired medicines for mental health and addiction. Comparable as a psychedelic therapy organization pursuing FDA approval, though commercial rather than nonprofit.
• Chacruna Institute: Established psychedelic education and advocacy nonprofit broader than AFI's ibogaine-only focus. Comparable as a long-running psychedelic advocacy/education organization with cultural and policy engagement.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xtwitter.com/americans4ibo
• Facebookfacebook.com/p/Americans-For-Ibogaine-61578715490744
• LinkedInlinkedin.com/company/americans-for-ibogaine
• Instagraminstagram.com/americans4ibo

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Americans for Ibogaine